News
Kung-Yee Liang, PH.D. was elected as the chairman of OBI Pharma, Inc.
OBI Pharma, Inc. (4174.TWO) held a board meeting today (29th) and unanimously elected Kung-Yee Liang PH.D., the new legal representative, former president of the National …
OBI Pharma proprietary ADC technology platform “plug and play”
site-specific conjugation, scalable manufacturing process, and suitability for various antibodies, linkers, or payload, establish a straightforward and efficient process in the development of ADC Antibody …
OBI Achieves ISO/IEC 27001 International Information Security Certification
After two years of continuous effort, OBI has successfully established an Information Security Management System and recently obtained ISO/IEC 27001 certification. SGS Group, responsible for …
OBI VOLUNTEERS ON A MISSION!
▲ OBI Volunteers Team. Photo / Provided by TBCA In Pink Oct , WHO designates it as ‘International Breast Cancer Awareness Month’ and calls for …
OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. appointed as Chief Executive Officer
Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision to bring innovative cancer …